Market revenue in 2019 | USD 43.3 million |
Market revenue in 2027 | USD 80.9 million |
Growth rate | 8.1% (CAGR from 2019 to 2027) |
Largest segment | Papillary carcinoma |
Fastest growing segment | Follicular Carcinoma |
Historical data | 2016 - 2018 |
Base year | 2019 |
Forecast period | 2020 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Papillary Carcinoma, Follicular Carcinoma |
Key market players worldwide | Abbott Laboratories, Roche, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, GE Aerospace, Koninklijke Philips NV, Toshiba Corporation, Agilent Technologies Inc, Illumina Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid cancer diagnostics market will help companies and investors design strategic landscapes.
Papillary carcinoma was the largest segment with a revenue share of 80.6% in 2019. Horizon Databook has segmented the South Korea thyroid cancer diagnostics market based on papillary carcinoma, follicular carcinoma covering the revenue growth of each sub-segment from 2016 to 2027.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea thyroid cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea thyroid cancer diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account